Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on May 2, 2025
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SAN FRANCISCO, May 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Celebrating One Year of 5-Star Urgent Care Services in Clear Lake, Houston
EIN Presswire
·
May 2, 2025
HOUSTON, TX, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- Priority Urgent Care and Walk-In Clinic - Clear Lake proudly celebrates its one-year anniversary of delivering exceptional, patient-centered urgent care services in Clear Lake, with a perfect …
Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
May 2, 2025
BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
May 2, 2025
FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
GlobeNewswire
·
May 2, 2025
SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
REDWOOD CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
NAARDEN, the Netherlands and MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
Global Hyperpigmentation Treatment Market Set to Surpass USD 12.4 Million by 2035 reflecting a CAGR of 9.0% | FMI
EIN Presswire
·
May 2, 2025
Emerging trends in AI-based skin assessment, rising preference for plant-based solutions, and expansion of medical-grade skincare to drive 9.0% CAGR growth NEWARK, DE, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- The global hyperpigmentation …
Hidradenitis Suppurativa Treatment Market Poised for Growth: Advancements in Therapeutics and Diagnostics | FMI
EIN Presswire
·
May 2, 2025
The expected to advance noticeably over the forecast period owing to ongoing research towards targeted biologic therapeutics and newer drug formulation. NEWARK, DE, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- The hidradenitis suppurativa treatment …
Just Blood Uncovers New Blood Testing Technology
GlobeNewswire
·
May 2, 2025
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- In a much-anticipated live demonstration on April 30, 2025, Laboratory expert and entrepreneur Ryan El-Hosseiny shut down Times Square in New York to unveil a new blood testing technology that he believes could …
Best Probiotics For Vaginal Health: Top Probiotics To Treat Bacterial Vaginosis [BV] & pH Balance – WOLFSON BRANDS (UK) LIMITED
GlobeNewswire
·
May 2, 2025
Glasgow, May 02, 2025 (GLOBE NEWSWIRE) -- Bacterial vaginosis or BV is a common scourge that affects most women at some point in their lives. It is a vaginal infection that invades the tissues of the vagina causing redness, soreness, extreme itching, …
WeaponUP Now Accepts HSA/FSA Payments Through Flex
EIN Presswire
·
May 2, 2025
MIAMI, FL, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- WeaponUP, the digital sword-yoga fusion platform, is proud to announce its new partnership with Flex, enabling customers to use their Health Savings Account (HSA) or Flexible Spending Account ( …
The Best SARMS for Cutting, Muscle Growth, Strength & Recovery - User Guide to Buying SARM Stacks for Bulking Cycles, Fat Loss & Shredding - CrazyBulk
GlobeNewswire
·
May 2, 2025
New York City, May 02, 2025 (GLOBE NEWSWIRE) -- There are around 10-12 SARMs commonly used in bodybuilding, each tailored to specific goals like bulking, cutting, or boosting strength and recovery. Many bodybuilders combine SARMs into stacks to amplify …
Health City Robotic Surgery Transforms the Lives of Fibroid Patients
EIN Presswire
·
May 2, 2025
CAYMAN ISLANDS, May 1, 2025 /EINPresswire.com/ -- After more than a decade of living with pain and complications from uterine fibroids, a Caribbean woman has found relief through robotic-assisted surgery at Health City Cayman Islands. Ayanna, 45, who …
Trial Finds Inquis Medical’s AVENTUS Thrombectomy System Safe and Effective for Patients with Pulmonary Embolism
GlobeNewswire
·
May 2, 2025
MENLO PARK, Calif. and WASHINGTON, May 02, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced results from its AVENTUS Trial evaluating the safety and efficacy of the company’s AVENTUS …
International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers
GlobeNewswire
·
May 2, 2025
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced the …
ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
GlobeNewswire
·
May 2, 2025
Vagal Neuromodulation Offers a Novel Approach to Treating Diabetes and Hypoglycemia Device Demonstrates the Ability to Modulate Glucose Levels Without Cardiac Side Effects, Overcoming a Key Limitation Of Conventional Vagal Stimulation Techniques IRVINE, …
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
GlobeNewswire
·
May 2, 2025
REYKJAVIK, Iceland, May 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for …
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 2, 2025
On track for six major study readouts across four programs over the next 12 months Ready to initiate pivotal studies in two developmental and epileptic encephalopathy (DEE) programs in mid-year 2025: EMERALD for broad DEEs with relutrigine and EMBRAVE3 for …